Found 14 matching trials
Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients
PHASE3The purpose of this study is to assess the safety, tolerability, and effica...
Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir
PHASE3This is an open, uncontrolled pilot study of thirty chronic HCV infected pa...
Location
Professor Yassin Abdel Ghaffar Charity Center for Liver Disease and Research
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
N/AObjectives: 1) To evaluate la proportion of hepatitic C virus (HCV)-monoinf...
Location
Valme University Hospital
DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)
PHASE2This is a prospective study to determine the incidence, morbidity, mortalit...
Location
Humanity and Health GI and Liver Centre
Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics
PHASE4This is a randomized, open label, single center safety and efficacy study. ...
Location
Southern California Research Center
Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]
PHASE2The primary objective of this pilot trial is to compare the efficacy, measu...
Location
YR Gaitonde Centre for AIDS Education and Johns Hopkins University Collaborative Integrated Care Center (YRG-JHU ICC)
Re-treatment of HCV Following DAA Failure
NAHCV infection is treated with oral drugs, termed as 'direct-acting anti-vir...
Location
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus
PHASE2This is an interventional Phase II/III, single center, single arm clinical ...
Location
Pediatric Department, Faculty of Medicine, Ain Shams University
Triple Combination DAAs for Treating HCV GT1b Subjects
PHASE2There is only one kind of treatment (simeprevir 150 mg + sofosbuvir 400 mg+...
Location
Humanity and Health Medical Centre
Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection
PHASE2This is a phase 2a, open-label, randomized study. The study is designed to ...
Location
Humanity & Health Research Centre